These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Risk factors for neuroleptic malignant syndrome. Francis A; Chandragiri S; Petrides G Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151 [No Abstract] [Full Text] [Related]
17. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. Ozen ME; Yumru M; Savas HA; Cansel N; Herken H World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349 [TBL] [Abstract][Full Text] [Related]
18. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone. Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333 [No Abstract] [Full Text] [Related]